The Transcriptional Role of Circular RNAs in Drug Resistance by Modulating the miRNA/mRNA Axis

Mohammad H Ghazimoradi1, Amirmohammad Moghadam1, Parastoo Akbarabadi1

  • 1Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.

PubMed

Insights

Circular RNAs (CRNA) regulate microRNAs (miRNA) to control messenger RNA (mRNA) degradation, impacting cancer drug resistance. This CRNA/miRNA/mRNA axis offers new insights into overcoming treatment challenges.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Research

Background:

  • Drug resistance significantly impairs cancer treatment efficacy and patient survival.
  • The precise mechanisms driving cancer drug resistance initiation and progression remain incompletely understood.
  • Noncoding RNAs, particularly circular RNAs, are increasingly recognized as critical epigenetic regulators implicated in various diseases, including cancer.

Purpose of the Study:

  • To elucidate the role of circular RNA (CRNA) in regulating microRNA (miRNA) activity within the context of cancer drug resistance.
  • To investigate the CRNA/miRNA/mRNA regulatory axis and its contribution to the development of cancer drug resistance.
  • To explore potential therapeutic targets by understanding the molecular mechanisms of CRNA-mediated drug resistance.

Main Methods:

  • Bioinformatic analysis to identify deregulated CRNA, miRNA, and mRNA expression profiles in resistant cancer models.
  • Experimental validation of CRNA-miRNA interactions and their impact on mRNA targets.
  • Functional assays to assess the role of the CRNA/miRNA/mRNA axis in conferring resistance to common cancer therapeutics.

Main Results:

  • Identified a novel regulatory axis where specific circular RNAs (CRNAs) modulate microRNA (miRNA) function.
  • Demonstrated that this CRNA/miRNA/mRNA interaction influences messenger RNA (mRNA) degradation pathways critical for drug resistance.
  • Observed dysregulation of multiple oncogenic and tumor-suppressive pathways mediated by this axis in common cancer types.

Conclusions:

  • The CRNA/miRNA/mRNA axis represents a key epigenetic mechanism driving cancer drug resistance.
  • Targeting this axis holds potential for developing novel strategies to overcome therapeutic resistance in cancer patients.
  • Further research into CRNA-mediated epigenetic regulation is crucial for advancing cancer treatment outcomes.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
72.4K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
8.9K